- Home
- CSTL vs CCAP Comparison
CSTL vs CCAP Comparison
Compare CSTL & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- CCAP
- Stock Information
- Founded
- CSTL 2007
- CCAP 2015
- Country
- CSTL United States
- CCAP United States
- Employees
- CSTL N/A
- CCAP N/A
- Industry
- CSTL Medical Specialities
- CCAP Finance: Consumer Services
- Sector
- CSTL Health Care
- CCAP Finance
- Exchange
- CSTL Nasdaq
- CCAP Nasdaq
- Market Cap
- CSTL 848.1M
- CCAP 706.0M
- IPO Year
- CSTL 2019
- CCAP N/A
- Fundamental
- Price
- CSTL $25.75
- CCAP $18.44
- Analyst Decision
- CSTL Strong Buy
- CCAP Buy
- Analyst Count
- CSTL 6
- CCAP 6
- Target Price
- CSTL $40.33
- CCAP $19.17
- AVG Volume (30 Days)
- CSTL 358.8K
- CCAP 112.8K
- Earning Date
- CSTL 02-27-2025
- CCAP 02-19-2025
- Dividend Yield
- CSTL N/A
- CCAP 1.08%
- EPS Growth
- CSTL N/A
- CCAP N/A
- EPS
- CSTL 0.21
- CCAP 1.99
- Revenue
- CSTL $311,878,000.00
- CCAP $197,363,000.00
- Revenue This Year
- CSTL $51.99
- CCAP $9.80
- Revenue Next Year
- CSTL N/A
- CCAP N/A
- P/E Ratio
- CSTL $122.41
- CCAP $9.28
- Revenue Growth
- CSTL 62.43
- CCAP 7.18
- 52 Week Low
- CSTL $16.97
- CCAP $16.58
- 52 Week High
- CSTL $35.84
- CCAP $20.19
- Technical
- Relative Strength Index (RSI)
- CSTL 37.34
- CCAP 29.87
- Support Level
- CSTL $26.65
- CCAP $19.46
- Resistance Level
- CSTL $28.48
- CCAP $20.19
- Average True Range (ATR)
- CSTL 1.12
- CCAP 0.34
- MACD
- CSTL -0.17
- CCAP -0.10
- Stochastic Oscillator
- CSTL 0.94
- CCAP 7.41
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About CCAP Crescent Capital BDC Inc. Common stock
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.